These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1524021)
1. Insulin and oral sulfonylureas in the treatment of diabetes mellitus. White JR Am Pharm; 1992 Aug; NS32(8):39-43. PubMed ID: 1524021 [No Abstract] [Full Text] [Related]
2. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients. Halimi S Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635 [No Abstract] [Full Text] [Related]
3. Exorcising the specter of nighttime hypoglycemia. Scheiner G Diabetes Self Manag; 2012; 29(1):16, 18-20. PubMed ID: 22482132 [No Abstract] [Full Text] [Related]
4. [Hypoglycemia in diabetes mellitus]. Irsigler K Acta Med Austriaca; 1992; 19(4):100-5. PubMed ID: 1290316 [TBL] [Abstract][Full Text] [Related]
6. Sulfonylureas in the treatment of diabetes mellitus--1985. Gerich JE Mayo Clin Proc; 1985 Jul; 60(7):439-43. PubMed ID: 3925246 [TBL] [Abstract][Full Text] [Related]
7. Oral sulfonylureas for the treatment of type II diabetes: an update. Shank WA; Morrison AD South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015 [TBL] [Abstract][Full Text] [Related]
8. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
9. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122 [TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes. Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160 [TBL] [Abstract][Full Text] [Related]
11. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM). Ponte CD W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas. Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA). Corsonello A; Pedone C; Corica F; Malara A; Carosella L; Sgadari A; Mauro VN; Ceruso D; Pahor M; Carbonin P Eur J Epidemiol; 1999 Nov; 15(10):893-901. PubMed ID: 10669122 [TBL] [Abstract][Full Text] [Related]
18. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
19. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113 [TBL] [Abstract][Full Text] [Related]
20. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy. Bell DS Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]